Spyre Therapeutics, Inc. (SYRE)

93.19 +3.26 (+3.62%) USD  |  NASDAQ  |  Oct 02, 16:00
93.19 0.00 (0.00%) After-Hours: 20:00
More

Spyre Therapeutics EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS LT Growth Estimates Data

View and export this data back to 2026. Start Trial.
Date Value
January 20, 2026 --

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
AbbVie, Inc. Upgrade
Incyte Corp. Upgrade
SELLAS Life Sciences Group, Inc. --
Relay Therapeutics, Inc. --
ACADIA Pharmaceuticals, Inc. Upgrade